GLSA
GLSA is a Philadelphia-based private network aggregator connecting life sciences sponsors, emerging biotechs, CROs, and clinical research sites with 200+ vetted global partners and fractionalized senior experts across preclinical and clinical development. Founded in 2020, it offers consulting, site community (GLSA Site Nexus), AI-enabled research services, and operational support on a fractional model.
- Company typePrivate
- Founded2020
- HeadquartersPhiladelphia, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What GLSA does
GLSA (Global Life Sciences Alliance, LLC) is a Philadelphia-based private network aggregator and fractionalized consulting services platform serving the life sciences industry. Founded in 2020, the company operates a curated ecosystem of 200+ vetted global partners including CDMOs, CROs, specialized laboratories, eClinical technology providers, and fractionalized senior executives (fractional CMOs, regulatory experts, clinical operations leaders). GLSA connects emerging biotech companies, pharmaceutical sponsors, clinical research sites, and CROs with on-demand expertise and service providers across the full preclinical-to-clinical development continuum, from IND-enabling studies and bioanalysis through Phase I-IV clinical trials, data management, licensing, and investor readiness support.
GLSA's service portfolio spans more than 15 distinct offerings including Preclinical & IND-Enabling Solutions, Global Clinical Research Solutions, Emerging Biotech Solutions, AI Drug Development & Clinical Research, Bioanalysis & Translational Science, eClinical Technologies (RTSM, EDC), Lab & Diagnostics, IRT & Clinical Supply Chain, Licensing & Strategic Partnering, Patient Recruitment & Diversity, Data Management & Biostatistics, Fractional HR, Talent Acquisition, and Business Services. The company also operates GLSA Site Nexus, a private community platform for clinical research site staff, along with sub-brands including GLSA Community Partners, Friends of Chris Matheus (FOCM), Women of Life Sciences (WoLS), and GLSA Accelerated Partnering. AI capabilities are positioned across clinical operations optimization, patient matching, predictive feasibility, and AI-assisted regulatory writing, though these are delivered primarily as advisory and integration services over third-party technology stacks rather than as proprietary AI products.
The business model is professional services and managed network services revenue, delivered through quote-based project, fractional, and retainer arrangements on a monthly billing cadence. Pricing is not publicly disclosed. GLSA employs 11-50 staff led by co-founders Denise McNerney (Chief Strategy & Operations Officer) and Chris Matheus (Chief Commercial & Networking Officer), supported by a global advisory network whose members contribute fractional capacity. Go-to-market is enterprise field sales driven by the founders' direct relationships, supplemented by channel distribution through the 200-partner network. The company is founder-controlled with no disclosed institutional investment or external funding rounds identified.
GLSA firmographics
Firmographics- Name
- GLSA
- Legal name
- Global Life Sciences Alliance, LLC
- Website
- https://globallifesciencesalliance.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- GLSA is a Philadelphia-based private network aggregator connecting life sciences sponsors, emerging biotechs, CROs, and clinical research sites with 200+ vetted global partners and fractionalized senior experts across preclinical and clinical development. Founded in 2020, it offers consulting, site community (GLSA Site Nexus), AI-enabled research services, and operational support on a fractional model.
- Ownership category
- akta.pro rank
GLSA industry classification
Industry- Product category
- Life Sciences Consulting Services
- NAICS
- Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169), Management Consulting Services (54161), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Management Consulting Services (8742), Services-Management Services (8741)
- akta.pro primary industry
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
- akta.pro secondary industries
- Investigator & Site Training / GCP Support (HLAGACAF), Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI), Commercial, Sales & Field Medical (MSL) Staffing FSP (HLAGAOAO), Regulatory Information Management (RIM) & Submission Publishing Software (HLAGAJAL)
Keywords
Where GLSA is headquartered
LocationHeadquarters
- HQ city
- Philadelphia
- HQ country
- United States
- HQ region
- North America
Markets served
GLSA business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Professional Services & Consulting: Fractionalized expertise and consulting services provided through a network of vetted partners and specialists. Services are offered on-demand, project-based, or retainer arrangements tailored to preclinical and clinical research needs.
- Network Partnership Services: GLSA Network facilitates curated connections between sponsors, CROs, sites and service providers, with partners able to offer services as full projects, fractional support, or specialized solutions.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Fractionalized/On-Demand Support |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
GLSA product offering
Product offeringCore offering
GLSA (Global Life Sciences Alliance) operates a curated network of 200+ fractionalized experts, CDMOs, CROs, labs, and specialized service partners that delivers end-to-end preclinical and clinical development solutions to life sciences organizations. The company provides on-demand, project-based, or retainer consulting arrangements covering discovery, IND-enabling studies, clinical trial management, vendor selection, bioanalysis, eClinical technologies, patient recruitment, licensing, and investor connections. Its core commercial model is relationship-driven direct engagement with sponsors, biotechs, and CROs, supplemented by a private community (GLSA Site Nexus) for clinical research sites.
Product overview
GLSA (Global Life Sciences Alliance) is a collaborative network of fractionalized experts, CDMOs, CROs, labs, and specialized service partners delivering preclinical and clinical development solutions across the life sciences ecosystem. The company offers a portfolio of interconnected service offerings including Preclinical & IND-Enabling Solutions, Global Clinical Research Solutions, Emerging Biotech Solutions, AI Drug Development & Clinical Research, Bioanalysis & Translational Science, eClinical Technologies (RTSM, EDC), Lab & Diagnostic Solutions, IRT & Clinical Supply Chain Solutions, Licensing & Strategic Partnering, Patient Recruitment & Diversity, Investor Readiness & Connections, Data Management & Biostatistics, and GLSA Site Nexus (a private community for clinical research site staff). Additional services include Fractional HR Services, Talent Acquisition, and Business Services. GLSA's network comprises 200+ global partners with over 100 years of combined experience, supporting organizations from early discovery through clinical trials, regulatory approval, licensing, and commercialization.
Differentiator
Problem solved
Functional benefit
Brands
- GLSA Site Nexus: A private, curated community exclusively for Clinical Research Site Staff providing study opportunities, peer networking, on-demand experts, and site education.
- GLSA Community Partners
- Friends of Chris Matheus (FOCM)
- GLSA AI Solutions
- GLSA Accelerated Partnering
- Women of Life Sciences (WoLS)
Products and services
- Preclinical & IND-Enabling Solutions Discovery, translational strategy, and IND-readiness support including toxicology, pharmacology, and IND-enabling studies delivered through fractional leadership and vetted global partners for biotech and pharma sponsors.
- Global Clinical Research Solutions End-to-end Phase I-IV clinical trial solutions delivered through global CRO partnerships, site networks, GLSA Site Nexus, eClinical systems, and specialized operational leadership for sponsors and emerging biotechs.
- Emerging Biotech Solutions Fractionalized executive leadership and full-service preclinical and clinical solutions for emerging biotech companies, supporting development from seed through clinical-stage execution.
- AI Drug Development & Clinical Research AI-powered predictive modeling, trial optimization, and predictive research integrating AI and machine learning across preclinical and clinical development to improve protocol optimization, feasibility, and patient matching.
- Bioanalysis & Translational Science Strategic bioanalysis, assay development, validation, and scientific oversight supporting small molecule, large molecule, translational, and biomarker programs with regulatory readiness and data integrity.
- eClinical Technologies Advanced eClinical systems including RTSM, EDC, AI-enabled workflows, and cybersecurity-focused technology infrastructure for digital trial execution, data integrity, and regulatory compliance.
- Lab & Diagnostic Solutions Central labs, genomic services, biomarker strategy, and diagnostic infrastructure supporting precision medicine, translational research, and clinical trials from discovery through commercialization.
- IRT & Clinical Supply Chain Solutions Integrated IRT, RTSM, global supply chain, cold-chain logistics, and investigational distribution solutions ensuring chain of custody, inventory transparency, and uninterrupted product delivery.
- Licensing & Strategic Partnering Global licensing, strategic partnering, asset commercialization, investor readiness, diligence preparation, and commercialization planning for biotech and life sciences innovators.
- Patient Recruitment, Advocacy & Diversity Patient recruitment experts, advocacy networks, call centers, and diversity-focused engagement solutions improving enrollment, retention, and representation aligned with FDA diversity initiatives.
- GLSA Investor Readiness & Connections Investor readiness, strategic growth, and capital alignment solutions supporting funding preparation, investor engagement, partnerships, and scalable growth for life sciences companies.
- Data Management & Biostatistics Biostatistics, clinical data management, governance, endpoint analysis, and regulatory reporting solutions improving trial precision, compliance, and strategic decision-making.
- GLSA Site Nexus Private, curated community exclusively for Clinical Research Site Staff providing study opportunities, quick feasibility requests, peer networking, on-demand experts, and site education, certifications, and training.
- Fractional HR Services Fractional human resources leadership and talent acquisition support for life sciences companies, including HR policy development, compliance audits, recruitment strategy, and organizational culture building.
- Talent Acquisition & Executive Search Life sciences talent acquisition connecting organizations with high-performing teams and helping professionals find meaningful career opportunities in biotech, pharma, and life sciences.
- Clinical Supply Chain & Logistics Consulting End-to-end clinical trial supply chain and logistics consulting including packaging, labeling, global distribution, cold-chain coordination, and last-mile delivery for investigational products.
- Business Services Strategic marketing, brand development, go-to-market execution, organizational development, and change management for life sciences companies.
- GLSA Network Partner Services Network of trusted CDMOs, CROs, labs, technology providers, and specialized service partners delivering end-to-end preclinical and clinical solutions to sponsors, sites, and emerging biotech companies.
Companies that use GLSA
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles4 records
GLSA technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability9 records
Feature4 records
GLSA partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core, major and minor.
- Clinical Research Sites & Site NetworkscoreGLSA Site Nexus connects sponsors and CROs with qualified clinical research sites. Sites gain visibility, study opportunities, peer networking, and access to shared resources and educational opportunities through a private community.
- Global Advisory NetworkcoreSenior advisors including fractional CMOs, regulatory experts, and specialized executives providing on-demand strategic guidance across preclinical and clinical development.
- CDMOs (Contract Development and Manufacturing Organizations)coreManufacturing and development partners within the 200+ partner network supporting preclinical through commercial production capabilities.
- CROs (Contract Research Organizations)coreGlobal CRO partnerships enabling clinical trial execution, operational support, and study management across all phases.
- Specialized Laboratories & DiagnosticscorePre-vetted lab partners for bioanalysis, biomarkers, central labs, genomics, and diagnostic services supporting translational research and clinical trials.
- eClinical Technology ProvidersmajorTechnology partners providing EDC, CTMS, eCOA, ePRO, RTSM, and integrated clinical platforms for digital trial infrastructure.
- Patient Recruitment & Advocacy PartnersmajorDigital marketing, community engagement, and AI-supported patient matching partners helping trials accelerate enrollment and improve retention.
- Women of Life Sciences (WoLS)minorLinkedIn community of 400+ women in life sciences with events, conversations, and networking initiatives supported by GLSA.
- FOCM (Friends of Chris Matheus)minorNetworking membership group hosting monthly virtual events for life sciences professionals, sponsors, and GLSA community.
Scale indicators4 records
Recent moves7 records
Expansion highlights6 records
GLSA competitors and assessment
Company assessmentBroad incumbents
- Syneos Health: Syneos Health provides clinical development and commercial services with a biopharmaceutical acceleration model. Comparable to GLSA's end-to-end positioning across clinical and commercialization, though Syneos operates owned delivery infrastructure.
- IQVIA: IQVIA is the largest global CRO and life sciences services conglomerate, offering clinical operations, real-world evidence, and technology. Comparable to GLSA in serving sponsors and biotechs across the full clinical development lifecycle, but at vastly greater scale and with owned infrastructure rather than a partner aggregator model.
- Charles River Laboratories: Charles River provides preclinical CRO services, CDMO capabilities, and research models. Comparable to GLSA's preclinical and IND-enabling solutions offering, though Charles River operates owned lab infrastructure at global scale.
- Labcorp Drug Development (Fortrea): Fortrea (spun out from Labcorp) is a major CRO providing clinical development, laboratory, and commercialization services. Comparable to GLSA across clinical operations and central lab services, though at much larger scale with owned assets.
- Medpace: Medpace is a mid-to-large CRO focused on emerging and mid-sized biotechs with full-service clinical development. Direct overlap with GLSA's primary emerging biotech segment, though Medpace operates owned regional operations versus GLSA's partner aggregator model.
- Parexel International: Parexel is a global CRO offering clinical operations, regulatory, biostatistics, and consulting services. Comparable to GLSA across clinical research solutions and regulatory services, though Parexel operates owned global infrastructure.
- ICON plc: ICON is a leading global CRO offering clinical research, consulting, and laboratory services across all phases. Comparable to GLSA in serving emerging biotechs and sponsors with end-to-end trial services, though ICON operates an owned-delivery model versus GLSA's partner-network aggregator approach.
Direct peers
- WCG (WIRB-Copernicus Group): WCG provides clinical trial solutions including IRB review, site optimization, and study activation services. Comparable to GLSA Site Nexus in particular, given both focus on site enablement, study startup acceleration, and sponsor-site connections across the clinical research ecosystem.
- Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized CRO specializing in complex clinical trials across multiple therapeutic areas. Comparable to GLSA in targeting mid-sized biotech and emerging pharma with flexible engagement models, though Worldwide delivers via owned operations.
Emerging players
- BioIQ (or equivalent fractional biotech services firm): BioIQ and similar fractional biotech advisory firms provide fractional leadership and operational support to emerging biotechs. Comparable to GLSA's Emerging Biotech Solutions and fractional executive offerings, though typically narrower in service scope.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
GLSA social profiles
Digital presenceGLSA financial estimates
Financial estimateRevenue estimate
Valuation estimate
GLSA leadership team
Management profileNumber of profiles
Profiles14 records
GLSA funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
GLSA M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about GLSA
What does GLSA do?
GLSA (Global Life Sciences Alliance) operates a curated network of 200+ fractionalized experts, CDMOs, CROs, labs, and specialized service partners that delivers end-to-end preclinical and clinical development solutions to life sciences organizations. The company provides on-demand, project-based, or retainer consulting arrangements covering discovery, IND-enabling studies, clinical trial management, vendor selection, bioanalysis, eClinical technologies, patient recruitment, licensing, and investor connections. Its core commercial model is relationship-driven direct engagement with sponsors, biotechs, and CROs, supplemented by a private community (GLSA Site Nexus) for clinical research sites.
Is GLSA a public or private company?
GLSA is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was GLSA founded?
GLSA was founded in 2020. It employs 11 to 50 people.
Where is GLSA based?
GLSA is headquartered in Philadelphia, United States, in the North America region.
How does GLSA make money?
Two revenue lines are on record. Professional Services & Consulting is the primary driver. The others are network Partnership Services.
Who are GLSA's main competitors?
Broad incumbents on record are Syneos Health, IQVIA, Charles River Laboratories, Labcorp Drug Development (Fortrea), Medpace, Parexel International and ICON plc. Direct peers are WCG (WIRB-Copernicus Group) and Worldwide Clinical Trials. BioIQ (or equivalent fractional biotech services firm) is listed as an emerging player.
Does GLSA have an API?
No public API is recorded for GLSA.
What industry is GLSA in?
GLSA's product category is Life Sciences Consulting Services. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF), with a secondary code of HLAGACAF, Investigator & Site Training / GCP Support. Its NAICS code is 5417 and its SIC code is 8731.